Overview


Canines are carnivores and will eat a variety of animals. Some can also eat vegetable matter and carrion. Canines are intelligent and easy to train. They were likely the first domesticated animals. Canine (family Canidae), also known as canid, is any one of 36 species of foxes or wolves that are currently alive. Canines are long, slender, bushy-tailed animals that can be found all over the globe. They have pointed ears and long muzzles. There are 36 species of canines. 12 genera were found. These include the genus Canis, Genus Vulpes, and genus Pseudalopex. This genus is distinguished by its large, well-developed skulls, dentition, short ears, and long tails. Pet owners look for quality healthcare products and veterinary services that will improve their pet's health and longevity. Pet owners around the world are making sure that pet care products meet human standards in terms of quality and manufacturing. Younger pet owners are making an effort to pamper their pets. Pet wellness products are in high demand. This is increasing the demand for canine drugs. Pet adoption is a key factor in driving the demand for animal nutrition products and behavioral products. This will help to accelerate sales. The demand for anti-obesity medications has increased with the increasing prevalence of obesity in pets over the last few years. The adoption rate of dogs is high, particularly among the elderly. This will drive demand for nutritional products, skin-care, and antibiotics for pets. Different diseases can be found in dogs. There are many drug options available for the treatment of canine diseases, including nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and parasiticides, vaccines, and hormonal drugs. The main factors driving the growth of the market for canine specialty medicines are canine adoption, canine health awareness, and R D.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Canine Specialty Drugs Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Canine Specialty Drugs Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

• Boehringer Ingelheim
• Merck animal Healtth
• Zoetis Animal Health
• Sanofi S.A.
• Elanco
• Novartis
• Virbac Group
• Vetoquinol S.A.
• Bayer Healthcare
• Ceva Sante Animale
(Note: The list of the major players will be updated with the latest market scenario and trends)

By Drug Type
• Nonsteroidal Anti-Inflammatory
o Carprofen
o Deracoxib
o Firocoxib
o Meloxicam
o Others
• Anti-infective
o Ketoconazole
o Doxycycline
o Others
• Parasiticides
o Nitenpyram
o Epsiprantel
o Spinosad
o Praziquantel
o Fipronil and methoprene
o Ivermectin
o Others
• Vaccines
o Core
o Non-Core
• Hormonal Drugs
o Levothyroxine
By Route of Administration
• Oral
• Parenteral
• Topical
By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

• To provide with an exhaustive analysis on the Canine Specialty Drugs Market By Drug Type, By Route of Administration and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Canine Specialty Drugs Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Drug Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Canine Specialty Drugs Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Canine Specialty Drugs Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Drug Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Drug Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Canine Specialty Drugs Market, By Drug Type Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Nonsteroidal Anti-Inflammatory
         1.1. Carprofen
         1.2. Deracoxib
         1.3. Firocoxib
         1.4. Meloxicam
         1.5. Others
        2. Anti-infective
         2.1. Ketoconazole
         2.2. Doxycycline
         2.3. Others
        3. Parasiticides
         3.1. Nitenpyram
         3.2. Epsiprantel
         3.3. Spinosad
         3.4. Praziquantel
         3.5. Fipronil and methoprene
         3.6. Ivermectin
         3.7. Others
        4. Vaccines
         4.1. Core
         4.2. Non-Core
        5. Hormonal Drugs
         5.1. Levothyroxine
  • 8.   Canine Specialty Drugs Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Oral
        2. Parenteral
        3. Topical
  • 9.   North America Canine Specialty Drugs Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 10.   Latin America Canine Specialty Drugs Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 11.   Europe Canine Specialty Drugs Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 12.   Asia Pacific Canine Specialty Drugs Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 13.   Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Boehringer Ingelheim
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Merck animal Healtth
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Zoetis Animal Health
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
          4. Sanofi S.A.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Elanco
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Ensinger
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Novartis
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Virbac Group
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
          9. Vetoquinol S.A.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Bayer Healthcare
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients